Related Experiment Video
Updated: Jan 22, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Precision medicine and health disparities: The case of pediatric acute lymphoblastic leukemia
Wylie Burke1, Kenneth Thummel2
1Department of Bioethics and Humanities, University of Washington, Seattle, WA.
Insights
Disparities in pediatric acute lymphoblastic leukemia (ALL) persist, with African American children facing worse outcomes. Addressing treatment access and cost is key to reducing these health inequities.
Area of Science:
- Oncology
- Health Disparities Research
- Genetics
Background:
- Precision medicine's role in addressing population health disparities remains uncertain.
- Pediatric acute lymphoblastic leukemia (ALL) serves as a case study for examining health inequities.
Purpose of the Study:
- To evaluate disparities in pediatric acute lymphoblastic leukemia (ALL) between African American (AA) and European American (EA) children.
- To assess the impact of genetic variations and treatment access on ALL outcomes.
Main Methods:
- A literature-based evaluation of pediatric ALL cases in African American and European American children.
- Analysis of incidence, relapse rates, prognostic indicators, environmental exposures, and genetic variants.
Main Results:
- African American children exhibit lower ALL incidence but higher relapse rates and poorer prognostic indicators compared to European American children.
- Environmental risk factors show small effect sizes, with insufficient data to determine their contribution to disparities.
- Genetic variants influence treatment response and relapse rates, but improved care settings mitigated these disparities.
Conclusions:
- Unequal access to effective treatment is a significant contributor to ALL disparities.
- Precision medicine holds potential for defining effective treatments tailored to diverse patient populations.
- Optimizing treatment protocols and eliminating financial barriers can reduce observed disparities in pediatric ALL outcomes.
Background:
Precision medicine has uncertain potential to address population health disparities.
Purpose:
Case study of disparities in pediatric acute lymphoblastic leukemia (ALL).
Method:
Literature-based evaluation of ALL in African American (AA) and European American (EA) children.
Findings:
AA children have a lower incidence of ALL than EA children, experience higher relapse rates, and are more likely to be diagnosed with poor prognostic indicators. Environmental risk exposures for ALL have small effect sizes; data are insufficient to determine their contribution to differences in incidence and prognosis. Differences in prevalence of gene variants associated with treatment response contribute to higher relapse rates in AA children. However, higher relapse rates were not seen in a care setting that eliminated out of pocket costs, used risk-directed therapy, and included rigorous case management.
Discussion:
Unequal access to effective treatment contributes to ALL disparities. Precision medicine can help to define effective treatment for diverse patient populations.
Related Concept Videos
Uncertainty in Measurement: Accuracy and Precision
Health Literacy
Accuracy and Precision
Microorganisms in Medicine and Therapeutics
Pharmacokinetics in Pediatric Patients: Drug Excretion
Purpose of Health Records I
Here's a breakdown of how health records serve these purposes:

